Researchers from Chungbuk National University (Cheongju, Republic of Korea) and the Cleveland Clinic’s Global Center for Human Health & Pathogen Research (OH, USA) have developed a potential vaccine candidate for COVID-19 using nanotechnology, with studies suggesting the vaccine candidate may be thermostable. The research was published in mBio, with results showing the vaccine produced potent neutralizing antibodies in preclinical models. A current challenge faced by many vaccines is the requirement for strict temperature control until the vaccine is administered, therefore a thermostable vaccine would avoid certain logistical challenges during transport and storage. Jae Jung (Cleveland Clinic), Director of the Global...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!